Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2014 2
2015 1
2018 1
2020 1
2021 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study.
Kim IA, Lee JS, Kim HJ, Kim WS, Lee KY. Kim IA, et al. BMC Cancer. 2018 Jul 28;18(1):768. doi: 10.1186/s12885-018-4691-0. BMC Cancer. 2018. PMID: 30055587 Free PMC article.
METHODS: We retrospectively analyzed 142 patients with EGFR-mutation positive advanced or recurrent lung adenocarcinoma who were administered gefitinib, erlotinib, afatinib, and osimertinib. ...Statistically significant negative association was observed …
METHODS: We retrospectively analyzed 142 patients with EGFR-mutation positive advanced or recurrent lung adenocarcinoma …
Comparison of endostatin combined with PT-DC versus bevacizumab combined with PT-DC in the first-line treatment of advanced lung adenocarcinoma: a retrospective propensity score-matched cohort study.
Chen X, Nie J, Dai L, Hu W, Zhang J, Han J, Ma X, Tian G, Han S, Wu D, Wang Y, Long J, Zhang Z, Fang J. Chen X, et al. Ann Palliat Med. 2021 Jul;10(7):7847-7856. doi: 10.21037/apm-21-1401. Ann Palliat Med. 2021. PMID: 34353072 Free article.
METHODS: This retrospective cohort study examined the clinical data of patients with metastatic or recurrent lung adenocarcinoma (LUAD) treated with endostatin or bevacizumab combined with PT-DC as the first-line treatment from October 2010 to November 2019. …
METHODS: This retrospective cohort study examined the clinical data of patients with metastatic or recurrent lung adenocarc …
Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report.
Fricke J, Mambetsariev I, Pharaon R, Subbiah S, Rajurkar S, Salgia R. Fricke J, et al. Medicine (Baltimore). 2020 Nov 13;99(46):e22323. doi: 10.1097/MD.0000000000022323. Medicine (Baltimore). 2020. PMID: 33181636 Free PMC article.
DIAGNOSIS: Surveillance imagine showed subcarinal and hilar lymphadenopathy, which was confirmed as recurrent lung adenocarcinoma via bronchoscopy. In addition, a brain scan showed a 5 mm enhancing left insular lesion. ...LESSONS: Immune checkpoint inhibitor- …
DIAGNOSIS: Surveillance imagine showed subcarinal and hilar lymphadenopathy, which was confirmed as recurrent lung adenocar …
Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.
Koriyama H, Ishii G, Yoh K, Neri S, Morise M, Umemura S, Matsumoto S, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A. Koriyama H, et al. J Cancer Res Clin Oncol. 2015 Jul;141(7):1163-70. doi: 10.1007/s00432-014-1891-0. Epub 2014 Dec 2. J Cancer Res Clin Oncol. 2015. PMID: 25446816
METHODS: We retrospectively analyzed 87 postoperative recurrent lung adenocarcinoma patients treated with platinum-based chemotherapy. The expressions of drug resistance-related proteins including BCRP, ezrin, and ALDH1 in cancer cells, the number of CD204-po …
METHODS: We retrospectively analyzed 87 postoperative recurrent lung adenocarcinoma patients treated with platinum-base …
Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment.
Okusanya OT, Deshpande C, Barbosa EM Jr, Aggarwal C, Simone CB 2nd, Jiang J, Judy R, DeJesus E, Albelda S, Nie S, Low PS, Singhal S. Okusanya OT, et al. Mol Imaging. 2014;13:10.2310/7290.2014.00051. doi: 10.2310/7290.2014.00051. Mol Imaging. 2014. PMID: 25442640 Free PMC article.
We describe the use of a folate-fluorescein conjugate to direct the biopsy of a suspected recurrent lung adenocarcinoma invading the mediastinum that had been previously treated with chemoradiation. We found that intraoperative imaging allowed the identificat …
We describe the use of a folate-fluorescein conjugate to direct the biopsy of a suspected recurrent lung adenocarcinoma …
Thai female non-smoker with recurrent lung adenocarcinoma who has dramatic and prolonged response to gefitinib for over one year.
Charoentum C. Charoentum C. J Med Assoc Thai. 2006 Jun;89(6):882-6. J Med Assoc Thai. 2006. PMID: 16850692
This result is consistent with previous reports that the clinical characteristics of female, non-smoker and adenocarcinoma histology seem to predict response to gefitinib....
This result is consistent with previous reports that the clinical characteristics of female, non-smoker and adenocarcinoma histology seem to …